DKDietmar Krex

Dietmar Krex

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dietmar Krex has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Gabriele Schackert

    Department of Neurosurgery, Carl Gustav Carus Hospital of University of Technology, Dresden, Germany

    7 shared publications
  • Andreas Ziegler

    Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    5 shared publications
  • Hans K. Schackert

    Surgical Research, University Hospital Carl Gustav Carus, University of Technology, Dresden, and

    5 shared publications
  • Inke Regina König

    Institut für Medizinische Biometrie und Statistik, University of Lübeck, Lübeck, Germany

    4 shared publications
  • Brigitte Mohr

    Departments of Internal Medicine, Hematology, and Oncology, University Hospital Carl Gustav Carus, University of Technology, Dresden, Germany

    2 shared publications
  • Hella Appelt

    Division of Surgical Research, University Hospital Carl Gustav Carus, University of Technology, Dresden, Germany

    2 shared publications

Latest Publications

  • A 6-gene signature for outcome prediction of grade II/III glioma.

    by Tim Lautenschlaeger, Alexander Huebner, Oliver Oehlke, Tareq A. Juratli, Bin Li, Wei Meng, Ahmed Ibrahim, Daniel Erny, Dietmar Krex, Gabriele Schackert, et al.

    2002 Background: Grade II and III gliomas are very heterogeneous in their outcome, leaving some uncertainty as to what the best treatment is for the individual patient. Methods: We used multiple datasets totaling 756 glioma patients to develop a prognostic 6-gene signature for grade II and III gliomas. Three risk groups were defined (low, medium, and high risk). This 6-gene classifier was then validated in multiple independent glioma data sets totaling over 500 patients and translated into a PCR-based assay. Results: The classifier was validated in a 214 grade II/III glioma patient independent validation set (TCGA, HR=4.03; 95% CI, 1.82-8.92; p= 0.001, for low vs high risk group) and a 287 patient grade IV glioblastoma set (updated TCGA, HR, 2.42; 95% CI, 1.69-3.47; p< 0.001, for low vs high risk group). The classifier was then translated into a PCR based assay in an independent 32 grade II/III glioma patient pilot cohort (multi-institutional, HR=6.3; 95% CI, 1.7-23.6; p= 0.006, for low vs high risk group). Multivariate Cox regressions validated the risk classifier independent of other clinical or molecular factors (grade, histology, IDH1 status) in all three data sets. ROC analysis for 3 year overall survival demonstrate that the classifier can predict 3 year survival better than grade, histology or IDH1 mutation status (AUC, 0.82; 95% CI, 0.70-0.93; p< 0.0001) in patients with grade II/III tumors. Of note, ROC analysis for 3 year overall survival demonstrated that the 6-gene classifier was also an excellent predictor of 3 year survival in glioblastoma (AUC, 0.84; 95% CI, 0.76-0.91; p< 0.0001). Conclusions: The 6-gene classifier can reliably predict 3-year outcome for patients older than 40 years and 7-year outcome for patients younger than 40 years old with grade 2 and 3 gliomas independent of histology, grade or IDH1 mutation status.


  • Open Access

    The Role of Endothelial Nitric Oxide Synthase (eNOS) Genetic Variants in European Patients with Intracranial Aneurysms

    by Dietmar Krex, Stefanie Fortun, Eberhard Kuhlisch, Hans K Schackert, Gabriele Schackert

    The endothelial nitric oxide synthase (eNOS) gene harbors three well-characterized genetic variants, which have been reported to be associated with various vascular diseases. Recently, conflicting results have been published relating to the role of these genetic variants in the pathogenesis of intracranial aneurysms (IA). Therefore, we analyzed these variants in a large European population of IA patients and controls. In all, 142 patients with IA and 190 controls were enrolled in our study. The −786T > C and 894G > T single-nucleotide polymorphisms (SNPs) were analyzed by direct sequencing of the corresponding sections in the genomic DNA. A variable number tandem repeat (VNTR) located in intron 4 of the gene and consisting of either four or five 27-base pair (bp) repeats was analyzed by polymerase chain reaction amplification and electrophoresis using ALF sequencer™ equipment. Genotype and allele frequencies were determined, and the frequencies in cases and controls were compared. In addition, haplotypes were constructed. There were no deviations from Hardy–Weinberg equilibrium. Genotype and allele frequencies did not differ significantly between cases and controls in any sample group or after stratification for multiple IA or aneurysm size. No single haplotype was significantly associated with the phenotype of an IA. The −786T > C, 894G > T, and 27-bp VNTR genetic variants of the eNOS gene are not associated with IA in the European population.


  • Open Access

    Extended Single Nucleotide Polymorphism and Haplotype Analysis of the elastin Gene in Caucasians with Intracranial Aneurysms Provides Evidence for Racially/Ethnically Based Differences

    by Dietmar Krex, Inke R. König, Andreas Ziegler, Hans K. Schackert, Gabriele Schackert

    Background: There is growing evidence that genetic variants have an impact on the pathogenesis of intracranial aneurysm (IA). Recently, the genetic locus around the elastin gene (7q11) has been identified as linked to IA in a Japanese population. Our aim was to confirm these results in Caucasian populations. Methods: We conducted a case-control study in 120 Caucasian patients with IA and 172 controls to investigate 8 single nucleotide polymorphisms (SNPs) and various haplotypes within the elastin gene, which were frequently found and associated with the phenotype in the Japanese populations. Real-time PCR and melting curve analysis were used for the detection of genotypes. Results: Allele frequencies and genotypes were equally distributed between Caucasian cases and controls. We failed to identify haplotypes that are associated with the phenotype in our population, which is in contrast to the Japanese study. However, allele frequencies in control populations differ between Caucasians and Japanese. Conclusions: We found no association between SNPs and haplotypes of the elastin gene and the occurrence of IA in our Caucasian populations. However, our data provide strong evidence for racial/ethnic differences in the association of SNP and specific haplotypes of the elastin gene with the phenotype. There might be other genetic variants of the elastin gene associated with IA in Caucasians.


  • Matrix Metalloproteinase-9 Coding Sequence Single-nucleotide Polymorphisms in Caucasians with Intracranial Aneurysms

    by Dietmar Krex, Kerstin Kotteck, Inke R. König, Andreas Ziegler, Hans K. Schackert, Gabriele Schackert

    OBJECTIVE:. There are several lines of evidence suggesting that matrix metalloproteinases (MMPs), particularly MMP-9, are involved in the pathogenesis o


  • Genetic Analysis of a Multifocal Glioblastoma Multiforme: A Suitable Tool to Gain New Aspects in Glioma Development

    by Dietmar Krex, Brigitte Mohr, Hella Appelt, Hans K. Schackert, Gabriele Schackert

    OBJECTIVE: Multifocal glioblastomas constitute an increasingly diagnosed subgroup of glioblastoma multiforme, the most malignant primary brain tumor in adults. The molecular background of these lesions is unknown. However, the ability to study multiple lesions of one patient simultaneously could provide new aspects in glioma development. METHODS: Short-term cell cultures were derived from three isolated glioblastoma lesions of one patient. Spectral karyotyping and interphase fluorescence in situ hybridization were used for cytogenetic analysis. Loss of heterozygosity was assessed in tumor tissues and cell lines for seven gene loci (p73, p21, p16, PTEN, p27, Rb, p53). In addition, sequence analysis of the PTEN and p53 loci was performed, epidermal growth factor receptor protein expression was assessed, and in vitro proliferation was assayed. RESULTS: A balanced translocation [t(1;15)(p3?6;q2?5)] that has not been described previously in glioblastomas was identified in all cell lines. Primarily, the cell lines have a homozygous deletion of the p16 locus and inactivation of the PTEN gene by loss of heterozygosity and an identical mutation in common. Furthermore, the cell lines harbor a hemizygous (R175H) or two heterozygous (R175H, R213Q) mutations of the p53 gene or none at all. The occurrence of p53 mutations correlates with the size of the original tumors and in vitro proliferation. CONCLUSION: The analysis of a multifocal glioma revealed three main aspects: 1) the combined cytogenetic and molecular analysis of this subgroup of glioblastoma multiforme is a suitable tool to gain new perspectives in glioma development, 2) the balanced translocation [t(1;15)(p3?6;q2?5)] might harbor a new genetic marker involved in glioma development, and 3) the pattern of p53 mutation suggests a role of p53 in the progression of malignancy, migration, and growth of this particular primary glioblastoma.


  • Tissue Inhibitor of Metalloproteinases-1, −2, and −3 Polymorphisms in a White Population With Intracranial Aneurysms

    by Dietmar Krex, Henning Röhl, Inke R. König, Andreas Ziegler, Hans K. Schackert, Gabriele Schackert

    Background and Purpose— Remodeling of the extracellular matrix seems to be a crucial event in the pathogenesis of cerebral aneurysms. Matrix metalloproteinases are the most important degrading enzymes in the extracellular matrix. Their activity is controlled predominantly by tissue inhibitors of metalloproteinases (TIMPs). To investigate the possible impact of genetic variants within the genes encoding TIMP-1, −2, and −3, we conducted this case-control study. Methods— A study sample was analyzed that comprised 44 patients with intracranial aneurysms and 44, 41, and 40 controls for the analysis of TIMP-1, −2, and −3, respectively. Differences in genotype and allele frequencies of identified polymorphisms were determined. The entire coding regions and parts of the promoter sequences of the TIMP-1, −2, and −3 genes were with using the automated laser fluorescence technique. Results— Nine polymorphisms were identified, 3 located in TIMP-1 (−19C>T, 261C>T, 372T>C), 4 in TIMP-2 (−621C>T, −596A>C, −261G>A, 303G>A), and 2 in TIMP-3 (249T>C, 261C>T), whereas −621C>T, −596A>C, and −261G>A of the TIMP-2 gene are newly identified polymorphisms. We detected no deviation from Hardy-Weinberg equilibrium in any of the groups. The C allele of the 372T>C polymorphism was more frequently found in female than in male controls (exact nominal P =0.0012). However, this finding could not be validated by analysis of a second sample of 113 controls (exact nominal P =1.0000). There were no differences in genotype and allele frequencies between any of the other groups. Conclusions— Our analysis of the entire coding region of 3 TIMPs, which are the main inhibitors of metalloproteinase activity in the extracellular matrix, failed to show an association between genetic polymorphisms and an intracranial aneurysm. These data do not support the hypothesis that genetic variants within these genes have an impact on aneurysm development in the white population.


  • Polymorphisms of the NADPH Oxidase p22phox Gene in a Caucasian Population with Intracranial Aneurysms

    by Dietmar Krex, Andreas Ziegler, Inke R. König, Hans K. Schackert, Gabriele Schackert

    Background: Vascular remodeling generated by reactive oxygen species contributes to aneurysm formation. The NADPH oxidase system is a major source of superoxide anion not only in phagocytes, but also in endothelial and vascular smooth muscle cells. Polymorphisms of p22phox, an essential component of the NADPH oxidase system, are found to be associated with atherosclerosis, while a recent study found a significant association between the 214C>T polymorphism and the occurrence of ischemic cerebrovascular disease. We conducted a case-control study to investigate the relationship of five polymorphisms of the p22phox gene and the occurrence of cerebral aneurysms. Methods: The study population consisted of 113 patients with intracranial aneurysms and 53 control subjects. The 214C>T polymorphism was investigated by restriction fragment length polymorphism analysis, while polymorphisms 381T>C, 480G>A, 521C>T, and *24A>G were analyzed by direct sequencing of exon 6 and adjacent intronic sequences. Results: The analysis of a primary study sample comprising 35 cases and 28 controls failed to show a significant association between any of the five polymorphisms and the occurrence of intracranial aneurysms using both allele frequencies and genotypes (all nominal p > 0.05). Although there was a deviation from Hardy-Weinberg equilibrium in cases at the 521C>T locus (nominal p < 0.05), this could not be confirmed in a second study sample of 78 patients. Haplotypes were constructed regarding three frequent polymorphisms (214C>T, 521C>T, and *24A>G); haplotype frequencies in cases and controls were not significantly different. Conclusion: Although polymorphisms of the p22phox gene located in the coding region and the 3′-untranslated region were reported to be associated with atherosclerosis and cerebrovascular disease, our data provide evidence that there is no association between these polymorphisms and the occurrence of cerebral aneurysms in Caucasians.


  • Physical and functional characterization of the human LGI1 gene and its possible role in glioma development

    by Dietmar Krex, Martin Hauses, Hella Appelt, Brigitte Mohr, Gerhard Ehninger, Hans Schackert, Gabriele Schackert

    The human gene termed LGI1 (leucine-rich gene – glioma inactivated) has been isolated recently, and is supposed to be an additional candidate tumor suppressor gene involved in the formation and progression of glioblastoma multiforme [Chernova et al. (1998) Oncogene 17:2873–2881]. To test this hypothesis and to complete the characterization of the gene, we performed various detailed studies on the genomic structure, the mRNA expression level, the integrity of the cDNA, and retroviral gene transfer into LGI1-deficient cell lines. Two single nucleotide polymorphisms in the promotor region and a highly polymorphic intragenic microsatellite repeat between exon 4 and 5 were found. Phylogenetic sequence analysis techniques were applied, which showed functional relationships between LGI1 and TRK and SLIT protein families that are known to be involved in development and maintenance of the nervous system. Fluorescence in situ hybridization (FISH) analysis showed LGI1 to be present on 10q24 in each of 11 glioma-derived cell lines evaluated. Sequence analysis of the LGI1 transcript did not detect any mutation. Relative amounts of LGI1 mRNA copy numbers as measured by the real-time fluorescence detection LightCycler technology differed more than three orders of magnitude and were significantly reduced in 10 of 11 cell lines. Retroviral gene transfer into LGI1-deficient glioma-derived cell lines could not substantiate any difference to control infected cultures regarding growth rate, S phase transition, and maintenance of marker gene expression. The strong homology to proteins involved in development, differentiation, or maintenance of the nervous system provides evidence for a function of the LGI1 protein in neural tissue. The observation that translocation or deletion of the LGI1 locus or mutation of the coding sequence of the LGI1 mRNA is not a frequent event in malignant glioma cell lines suggests that epigenetic factors lead to substantial differences in the amount of LGI1 mRNA expression. In addition, that the effect is lacking after retroviral gene transfer in cell culture suggests that binding of some kind of a ligand is essential for its biological activity.


  • Lack of Association Between Endoglin Intron 7 Insertion Polymorphism and Intracranial Aneurysms in a White Population: Evidence of Racial/Ethnic Differences

    by Dietmar Krex, Andreas Ziegler, Hans Konrad Schackert, Gabriele Schackert

    Background and Purpose— Endoglin is a component of the transforming growth factor-β receptor complex and is predominantly expressed on cell surfaces of endothelial cells. A polymorphism of the endo...